Key result
Review outlines the link between cancer and HF, highlighting chemotherapy cardiotoxicity and current management.
Why the study?
Cancer and heart failure are increasingly relevant worldwide both epidemiologically and clinically, prompting a review of their relationship, shared risk factors, and chemotherapy-related cardiotoxicity.
Answers are grounded in this paper and cite their sources.
This review summarizes the current evidence on the relationship between cancer and heart failure, including chemotherapy-induced cardiotoxicity and its management.
Cancer and heart failure (HF) are increasingly relevant worldwide, both from an epidemiologic and clinical point of view. This review aims to explore the relationship between cancer and HF by underscoring risk factors and disclosing the cardiotoxic effects of the current chemotherapy agents. We also deal with the current evidence on the diagnosis and management of HF related to cancer therapy. Finally, we will address the main gaps in knowledge and future perspectives in this field.
No takes yet. Share an insight, caveat, or question.
Bertolini et al. (2024) conducted a review in Cancer and Heart Failure. This review explores the relationship between cancer and heart failure, highlighting risk factors, cardiotoxic effects of chemotherapy, and current evidence on diagnosis and management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: